Keisuke Shioji

2.0k total citations
55 papers, 1.5k citations indexed

About

Keisuke Shioji is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Keisuke Shioji has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 20 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Keisuke Shioji's work include Viral Infections and Immunology Research (20 papers), Redox biology and oxidative stress (12 papers) and Vitamin C and Antioxidants Research (7 papers). Keisuke Shioji is often cited by papers focused on Viral Infections and Immunology Research (20 papers), Redox biology and oxidative stress (12 papers) and Vitamin C and Antioxidants Research (7 papers). Keisuke Shioji collaborates with scholars based in Japan, United States and Canada. Keisuke Shioji's co-authors include Chiharu Kishimoto, Hajime Nakamura, Zuyi Yuan, Shigetake Sasayama, Junji Yodoi, Hiroshi Masutani, Yoshihiro Kokubo, Naoharu Iwai, Junji Yodoi and Shinichi Oka and has published in prestigious journals such as Circulation, Circulation Research and FEBS Letters.

In The Last Decade

Keisuke Shioji

53 papers receiving 1.4k citations

Peers

Keisuke Shioji
Meilei Ma Japan
Sivaram Pillarisetti United States
María Miana Spain
Tomonari Koike Japan
Shin-ichiro Miura Japan
Hiroshi Mokuno Japan
Subhash K. Das Canada
Xian-Cheng Jiang United States
Shawna A. Cooper United States
Peter Libby United States
Meilei Ma Japan
Keisuke Shioji
Citations per year, relative to Keisuke Shioji Keisuke Shioji (= 1×) peers Meilei Ma

Countries citing papers authored by Keisuke Shioji

Since Specialization
Citations

This map shows the geographic impact of Keisuke Shioji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Shioji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Shioji more than expected).

Fields of papers citing papers by Keisuke Shioji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Shioji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Shioji. The network helps show where Keisuke Shioji may publish in the future.

Co-authorship network of co-authors of Keisuke Shioji

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Shioji. A scholar is included among the top collaborators of Keisuke Shioji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Shioji. Keisuke Shioji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torii, Sho, Akihiko Takahashi, Masanori Taniwaki, et al.. (2025). Single catheter primary percutaneous coronary intervention method in patients with ST-elevation myocardial infarction: the SPEEDY-PCI study. Cardiovascular Intervention and Therapeutics. 40(4). 807–819.
2.
Sasa, Tomoki, et al.. (2022). A 17-year-old male with acute myocarditis following mRNA-1273 vaccination in Japan. Journal of Cardiology Cases. 26(2). 108–110. 2 indexed citations
3.
Ogawa, Tatsuya, et al.. (2016). Aortic valve replacement with a 17-mm mechanical prosthesis in octogenarian or older patients. Journal of Thoracic and Cardiovascular Surgery. 152(1). 112–117. 2 indexed citations
4.
Kishimoto, Chiharu, Keisuke Shioji, Tetsuo Hashimoto, et al.. (2013). Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart and Vessels. 29(3). 336–342. 39 indexed citations
5.
Kishimoto, Chiharu, et al.. (2012). Immunoglobulin treatment ameliorates myocardial injury in experimental autoimmune myocarditis associated with suppression of reactive oxygen species. International Journal of Cardiology. 167(1). 140–145. 5 indexed citations
6.
Baba, Osamu, Masayasu Izuhara, Shin Kadota, et al.. (2009). Determinant factors of plasma B-type natriuretic peptide levels in patients with persistent nonvalvular atrial fibrillation and preserved left ventricular systolic function. Journal of Cardiology. 54(3). 402–408. 6 indexed citations
7.
Kadota, Shin, Mitsuo Matsuda, Masayasu Izuhara, et al.. (2009). A case of right atrial angiosarcoma: The utility of PET and CT fusion imaging in detecting a malignant cardiac tumor. Journal of Cardiology Cases. 1(2). e84–e87. 4 indexed citations
8.
Shioji, Keisuke, Masayasu Izuhara, Shin Kadota, et al.. (2009). A case of marked ST depression and myocardial injury as a result of disulfiram–ethanol reaction. Journal of Cardiology Cases. 1(3). e137–e140. 1 indexed citations
9.
Kadota, Shin, Yuzo Takeuchi, Masayasu Izuhara, et al.. (2008). The importance of serial cardiac troponin measurement for evaluating the response to immunosuppressive therapy for myocarditis. Journal of Cardiology. 52(2). 154–158. 5 indexed citations
10.
Kadota, Shin, Mitsuo Matsuda, Masayasu Izuhara, et al.. (2008). Long-term effects of early statin therapy for patients with acute myocardial infarction treated with stent implantation. Journal of Cardiology. 51(3). 171–178. 11 indexed citations
11.
Kuwahara, Takashi, et al.. (2005). Identification of a novel insertion mutation in GATA3 with HDR syndrome. Clinical and Experimental Nephrology. 9(1). 58–61. 23 indexed citations
12.
Yuan, Zuyi, et al.. (2005). Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 289(3). H1147–H1152. 30 indexed citations
13.
Kishimoto, Chiharu, et al.. (2004). Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis. Molecular and Cellular Biochemistry. 259(1-2). 217–222. 14 indexed citations
14.
Shioji, Keisuke, Toshifumi Mannami, Yoshihiro Kokubo, et al.. (2004). Genetic variants in PCSK9 affect the cholesterol level in Japanese. Journal of Human Genetics. 49(2). 109–114. 71 indexed citations
15.
Iwai, Naoharu, Naomi Tago, Naomi Yasui, et al.. (2004). Genetic analysis of 22 candidate genes for hypertension in the Japanese population. Journal of Hypertension. 22(6). 1119–1126. 45 indexed citations
16.
Yuan, Zuyi, et al.. (2004). Cardioprotective effects of carvedilol on acute autoimmune myocarditis. Molecular and Cellular Biochemistry. 259(1-2). 223–228. 14 indexed citations
17.
Shioji, Keisuke, Toshifumi Mannami, Yoshihiro Kokubo, et al.. (2004). An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese. Journal of Human Genetics. 49(8). 433–439. 27 indexed citations
18.
Miwa, Kunihisa, Chiharu Kishimoto, Hajime Nakamura, et al.. (2003). Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina. Clinical Cardiology. 26(4). 177–181. 28 indexed citations
19.
Ono, Koh, Yoshitaka Iwanaga, Toshifumi Mannami, et al.. (2003). Epidemiological Evidence of an Association between SLC6A2 Gene Polymorphism and Hypertension. Hypertension Research. 26(9). 685–689. 23 indexed citations
20.
Yuan, Zuyi, Chiharu Kishimoto, Hideto Sano, et al.. (2003). Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion. American Journal of Physiology-Heart and Circulatory Physiology. 285(2). H899–H906. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meilei Ma Breakdown of academic impact, for papers by Sivaram Pillarisetti Breakdown of academic impact, for papers by María Miana Breakdown of academic impact, for papers by Tomonari Koike Breakdown of academic impact, for papers by Shin-ichiro Miura Breakdown of academic impact, for papers by Hiroshi Mokuno Breakdown of academic impact, for papers by Subhash K. Das Breakdown of academic impact, for papers by Xian-Cheng Jiang Breakdown of academic impact, for papers by Shawna A. Cooper Breakdown of academic impact, for papers by Peter Libby
Rankless by CCL
2026